Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04610944 · ClinicalTrials.gov registry record · NA

Changing Talk Online Training (CHATO) National Trial

A NA study of Alzheimer Disease and Dementia, sponsored by University of Kansas Medical Center.

Active
Registry status
NA
Development phase
5,043
Enrollment target
1
Study location

NCT04610944: Active NA study of Alzheimer Disease and Dementia, sponsored by University of Kansas Medical Center.

NCT04610944 is a NA study of Alzheimer Disease and Dementia that is active but no longer recruiting, run by University of Kansas Medical Center. The registered enrollment target is 5,043 participants, above the 2,734-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (84% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04610944, a NA study of Alzheimer Disease and Dementia, is active but no longer recruiting, sponsored by University of Kansas Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
5,043 participants
Enrollment target
1
Study location

Study Summary

The National Plan to Address Alzheimer's disease has identified education of dementia care providers as a top priority to address the need for quality care for the population of persons with dementia that will triple in the next 30 years. This study will test new online interactive training for nursing home staff that improves staff communication and also reduces behavioral symptoms of persons with dementia that they care for. Innovative approaches to reach care providers are essential to achieve implementation of evidence-based practices to improve care.

Primary Outcome

CMS MDS Quarterly data - E0200 Presence and Frequency of Behavioral Symptoms in the last 7 days; The steps for assessment are to review the medical record, observe the resident in a variety of situations, and interview staff, across all shifts and disciplines. Coding Instruction: Code 0, behavior not exhibited, Code 1, behavior of this type occurred 1-3 days, Code 2, behavior of this type occurred 4-6 days, but less than daily, or Code 3, behavior of this type occurred daily.

Interventions

  • BEHAVIORAL Changing Talk Online (CHATO)

Study Locations (1)

Kansas

  • University of Kansas School of Nursing - Kansas City

Trial Details

FieldValue
Enrollment Target 5,043 participants
Start Date 2021-04-26
Est. Completion 2026-05-31
Phase NA
University of Kansas Medical Center

408 total trials

What the registry record for NCT04610944 still lists

NCT04610944 is an interventional study that assigns participants to a tested intervention. Its 5,043 participants enrollment target places it among the larger protocols in the corpus, above the 2,734-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (84% higher).

The record links to 3 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Changing Talk Online (CHATO) is the first listed.

NCT04610944 reports a single indexed study location in Kansas.

Frequently Asked Questions

What is clinical trial NCT04610944 about?

NCT04610944 is a clinical study titled "Changing Talk Online Training (CHATO) National Trial". The National Plan to Address Alzheimer's disease has identified education of dementia care providers as a top priority to address the need for quality care for the population of persons with dementia that will triple in the next 30 years. This study will test new online interactive training for nurs...

What is the current status of trial NCT04610944?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 5,043 participants. The study started on 2021-04-26. Estimated completion is 2026-05-31.

What conditions does trial NCT04610944 study?

This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Communication.

What interventions are being tested in trial NCT04610944?

The interventions under investigation include: Changing Talk Online (CHATO) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04610944?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04610944 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04610944's enrollment target sits among peer trials

5,043 15th of 306 higher than 292 of 306 other Alzheimer Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07037459 · 5,056 participants · Phase 3

    Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • NCT06292078 · 5,076 participants · NA

    Preventing School Exclusion and Opioid Misuse: Effectiveness of the Inclusive Skill-building Learning Approach (ISLA)

  • NCT04743362 · 5,010 participants

    A Study of Noninvasive Methods to Evaluate Skin and Mucosal Conditions

  • NCT00060541 · 5,000 participants

    Evaluation and Treatment of Neurosurgical Disorders

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04610944, the US trial registry maintained by the National Library of Medicine. NCT04610944 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.